ABT-199 50mg 50mg | Purity Not Available
Adooq Bioscience
ABT-199 is a so-called BH3-mimetic drug, which is designed to block the function of the protein Bcl 2.
More Information Supplier PageABT-199 is a so-called BH3-mimetic drug, which is designed to block the function of the protein Bcl 2.
More Information Supplier PageABT-199 is a so-called BH3-mimetic drug, which is designed to block the function of the protein Bcl 2.
More Information Supplier PageABT-199 is a so-called BH3-mimetic drug, which is designed to block the function of the protein Bcl 2.
More Information Supplier PageABT-199 is a so-called BH3-mimetic drug, which is designed to block the function of the protein Bcl 2.
More Information Supplier PageVU 0361737 is a selective positive allosteric modulator at mGluR-4 (EC50 values are 240 and 110 nM at human and rat receptors respectively).
More Information Supplier PageVU 0361737 is a selective positive allosteric modulator at mGluR-4 (EC50 values are 240 and 110 nM at human and rat receptors respectively).
More Information Supplier PageVU 0361737 is a selective positive allosteric modulator at mGluR-4 (EC50 values are 240 and 110 nM at human and rat receptors respectively).
More Information Supplier PageAT13148 is a novel oral multi-AGC kinase inhibitor with potent pharmacodynamic and antitumor activity, which shows a distinct mechanism of action from other AKT inhibitors.
More Information Supplier PageAT13148 is a novel oral multi-AGC kinase inhibitor with potent pharmacodynamic and antitumor activity, which shows a distinct mechanism of action from other AKT inhibitors.
More Information Supplier PageAT13148 is a novel oral multi-AGC kinase inhibitor with potent pharmacodynamic and antitumor activity, which shows a distinct mechanism of action from other AKT inhibitors.
More Information Supplier Page